Goldman Sachs’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.3M Sell
2,347,443
-865,342
-27% -$6.72M ﹤0.01% 2331
2025
Q4
$25.1M Buy
3,212,785
+500,979
+18% +$3.62M ﹤0.01% 2159
2025
Q3
$20.6M Sell
2,711,806
-812,111
-23% -$6.76M ﹤0.01% 2244
2025
Q2
$31.6M Buy
3,523,917
+1,591,983
+82% +$14.8M 0.01% 1710
2025
Q1
$14.5M Buy
1,931,934
+640,704
+50% +$5.17M ﹤0.01% 2336
2024
Q4
$9.71M Sell
1,291,230
-1,029,299
-44% -$7.81M ﹤0.01% 2838
2024
Q3
$17.6M Sell
2,320,529
-209,730
-8% -$1.59M ﹤0.01% 2181
2024
Q2
$15.6M Buy
2,530,259
+604,894
+31% +$3.34M ﹤0.01% 2082
2024
Q1
$9.78M Buy
1,925,365
+150,611
+8% +$847K ﹤0.01% 2472
2023
Q4
$10.6M Buy
1,774,754
+232,043
+15% +$1.34M ﹤0.01% 2473
2023
Q3
$10.9M Buy
1,542,711
+63,922
+4% +$459K ﹤0.01% 2313
2023
Q2
$10.4M Buy
1,478,789
+352,083
+31% +$2.83M ﹤0.01% 2407
2023
Q1
$9.4M Sell
1,126,706
-4,988
-0.4% -$48K ﹤0.01% 2481
2022
Q4
$13M Sell
1,131,694
-337,461
-23% -$4.21M ﹤0.01% 2340
2022
Q3
$18.5M Buy
1,469,155
+92,443
+7% +$1.19M 0.01% 1940
2022
Q2
$14.6M Buy
1,376,712
+103,087
+8% +$1.06M ﹤0.01% 2161
2022
Q1
$20.7M Buy
1,273,625
+459,965
+57% +$7.38M 0.01% 2023
2021
Q4
$11.3M Buy
813,660
+45,965
+6% +$608K ﹤0.01% 2651
2021
Q3
$11M Sell
767,695
-42,467
-5% -$670K ﹤0.01% 2625
2021
Q2
$12.8M Sell
810,162
-1,360,428
-63% -$18.5M ﹤0.01% 2462
2021
Q1
$22.1M Buy
2,170,590
+1,866,955
+615% +$19.3M 0.01% 1852
2020
Q4
$2.26M Sell
303,635
-1,166,305
-79% -$6.01M ﹤0.01% 3639
2020
Q3
$5.05M Sell
1,469,940
-754,732
-34% -$3.23M ﹤0.01% 2895
2020
Q2
$10.6M Buy
2,224,672
+760,132
+52% +$3.04M ﹤0.01% 2225
2020
Q1
$2.93M Buy
1,464,540
+341,261
+30% +$940K ﹤0.01% 3040
2019
Q4
$3.88M Buy
1,123,279
+80,648
+8% +$203K ﹤0.01% 3161
2019
Q3
$2.99M Buy
1,042,631
+36,924
+4% +$115K ﹤0.01% 3240
2019
Q2
$3.81M Buy
1,005,707
+622,093
+162% +$3.74M ﹤0.01% 3047
2019
Q1
$3.12M Buy
383,614
+229,103
+148% +$1.96M ﹤0.01% 3317
2018
Q4
$1.25M Buy
154,511
+10,043
+7% +$78.1K ﹤0.01% 3844
2018
Q3
$1.1M Buy
144,468
+45,674
+46% +$307K ﹤0.01% 3993
2018
Q2
$566K Sell
98,794
-1,615
-2% -$8.89K ﹤0.01% 4436
2018
Q1
$479K Sell
100,409
-83,234
-45% -$428K ﹤0.01% 4524
2017
Q4
$901K Sell
183,643
-177,294
-49% -$859K ﹤0.01% 4402
2017
Q3
$1.89M Sell
360,937
-563,820
-61% -$2.89M ﹤0.01% 4050
2017
Q2
$5.14M Buy
924,757
+137,068
+17% +$835K ﹤0.01% 3029
2017
Q1
$6.62M Buy
787,689
+46,249
+6% +$322K ﹤0.01% 2707
2016
Q4
$4.69M Sell
741,440
-155,302
-17% -$808K ﹤0.01% 3108
2016
Q3
$3.96M Sell
896,742
-249,338
-22% -$996K ﹤0.01% 3249
2016
Q2
$3.25M Sell
1,146,080
-91,338
-7% -$284K ﹤0.01% 3206
2016
Q1
$3.5M Buy
1,237,418
+155,133
+14% +$688K ﹤0.01% 2992
2015
Q4
$11.2M Buy
1,082,285
+52,515
+5% +$522K ﹤0.01% 2170
2015
Q3
$11.7M Sell
1,029,770
-3,394
-0.3% -$45.3K 0.01% 2123
2015
Q2
$15.4M Buy
1,033,164
+596
+0.1% +$6.78K 0.01% 1999
2015
Q1
$9.32M Buy
1,032,568
+774,093
+299% +$8.01M ﹤0.01% 2349
2014
Q4
$3.14M Buy
258,475
+223,158
+632% +$2.46M ﹤0.01% 3410
2014
Q3
$345K Buy
35,317
+13,309
+60% +$163K ﹤0.01% 5621
2014
Q2
$281K Sell
22,008
-4,333
-16% -$42.2K ﹤0.01% 5908
2014
Q1
$279K Sell
26,341
-72,461
-73% -$773K ﹤0.01% 5797
2013
Q4
$751K Sell
98,802
-86,139
-47% -$545K ﹤0.01% 4984
2013
Q3
$1.35M Sell
184,941
-21,834
-11% -$111K ﹤0.01% 4316
2013
Q2
$321K Buy
+206,775
New +$357K ﹤0.01% 5279

Other funds holding BCRX